Medicare Part D Update — Lessons Learned and Unfinished Business

Patricia Neuman · Juliette Cubanski

54 citations0/0 files storedNew England Journal of Medicine

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Healthcare Policy and Management Healthcare Systems and Reforms Pharmaceutical Economics and Policy

Abstract

In this report, the authors review the experience to date with the Medicare Part D prescription-drug plan and discuss the challenges facing policymakers.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 54 citations exist upstream.

References

2007The Impact Of Medicare Part D On Prescription Drug Use By The Elderly 2008The Effect of the Medicare Part D Prescription Benefit on Drug Utilization and Expenditures 2007Medicare Prescription Drug Benefit Progress Report: Findings From A 2006 National Survey Of Seniors 2008Prescription Drug Spending Trends In The United States: Looking Beyond The Turning Point 2006Who Failed To Enroll In Medicare Part D, And Why? Early Results 2009The Effect Of Medicare Part D Coverage On Drug Use And Cost Sharing Among Seniors Without Prior Drug Benefits 2009The Effects Of The Coverage Gap On Drug Spending: A Closer Look At Medicare Part D 2008Should Drug Prices Be Negotiated Under Part D Of Medicare? And If So, How?

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

Imported from OpenAlex (CC0) — nothing here is generated.